Literature DB >> 32052074

The bidirectional relationship between chronic obstructive pulmonary disease and coronary artery disease.

Ayham Daher1, Michael Dreher2.   

Abstract

Chronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD) not only have smoking as a common risk factor, they also share epidemiological relationships and important mutual effects. There is good evidence to suggest that COPD is highly prevalent but underdiagnosed among CAD patients and vice versa. The symptoms of the two diseases can overlap, making differential diagnosis challenging. This highlights the importance of pulmonary function tests (PFTs) in patients with CAD but also a cardiological assessment in patients with COPD. Chronic obstructive pulmonary disease is a risk factor for the development of CAD independent of other cardiovascular risk factors, and the presence of COPD worsens prognosis in patients with CAD. Mechanisms underlying the associations between COPD and CAD have been less well studied, but inflammation is increasingly being recognized as an important factor linking the two diseases. Other potential contributors include increased oxidative stress, platelet activation, and arterial stiffness. The influence of medications used to treat one condition on the other one needs to be understood and taken into account in patient management. Physicians need to be aware of the important links between COPD and CAD, both of which are commonly encountered in clinical practice. This should help to optimize the management of both conditions to improve patient outcomes.

Entities:  

Keywords:  Atherosclerosis; COPD; Inflammation; Morbidity; Mortality

Mesh:

Year:  2020        PMID: 32052074     DOI: 10.1007/s00059-020-04893-4

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  79 in total

Review 1.  Atherosclerosis is an inflammatory disease.

Authors:  R Ross
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

2.  An epidemiological study of the effects of statin use on airflow limitation in patients with chronic obstructive pulmonary disease.

Authors:  Masashi Bando; Tadashi Miyazawa; Hideki Shinohara; Toshio Owada; Michiyuki Terakado; Yukihiko Sugiyama
Journal:  Respirology       Date:  2012-04       Impact factor: 6.424

3.  Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study.

Authors:  M W Knuiman; A L James; M L Divitini; G Ryan; H C Bartholomew; A W Musk
Journal:  Ann Epidemiol       Date:  1999-07       Impact factor: 3.797

4.  Association of lung function with coronary heart disease and cardiovascular disease outcomes in elderly: the Rancho Bernardo study.

Authors:  Hwa Mu Lee; Michael A Liu; Elizabeth Barrett-Connor; Nathan D Wong
Journal:  Respir Med       Date:  2014-10-06       Impact factor: 3.415

5.  Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from "men born in 1914," Malmö, Sweden.

Authors:  G Engström; P Wollmer; B Hedblad; S Juul-Möller; S Valind; L Janzon
Journal:  Circulation       Date:  2001-06-26       Impact factor: 29.690

Review 6.  Mortality in COPD: Role of comorbidities.

Authors:  D D Sin; N R Anthonisen; J B Soriano; A G Agusti
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

7.  Lung Function Abnormalities in Smokers with Ischemic Heart Disease.

Authors:  Frits M E Franssen; Joan B Soriano; Nicolas Roche; Paul H Bloomfield; Guy Brusselle; Leonardo M Fabbri; Francisco García-Rio; Mark T Kearney; Namhee Kwon; Bo Lundbäck; Klaus F Rabe; Alice Raillard; Hana Muellerova; John R Cockcroft
Journal:  Am J Respir Crit Care Med       Date:  2016-09-01       Impact factor: 21.405

8.  Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation.

Authors:  P H Brekke; T Omland; S H Holmedal; P Smith; V Søyseth
Journal:  Eur Respir J       Date:  2007-11-21       Impact factor: 16.671

Review 9.  Circulating biomarkers of oxidative stress in chronic obstructive pulmonary disease: a systematic review.

Authors:  Elisabetta Zinellu; Angelo Zinellu; Alessandro Giuseppe Fois; Ciriaco Carru; Pietro Pirina
Journal:  Respir Res       Date:  2016-11-14

10.  Coronary lesions in patients with COPD (Global Initiative for Obstructive Lung Disease stages I-III) and suspected or confirmed coronary arterial disease.

Authors:  Igor Larchert Mota; Antônio Carlos Sobral Sousa; Maria Luiza Doria Almeida; Enaldo Vieira de Melo; Eduardo José Pereira Ferreira; José Barreto Neto; Carlos José Oliveira Matos; Caio José Coutinho Leal Telino; Maria Júlia Silveira Souto; Joselina Luzia Menezes Oliveira
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-06-26
View more
  2 in total

1.  Factors affecting brain structure in smoking-related diseases: Chronic Obstructive Pulmonary Disease (COPD) and coronary artery disease.

Authors:  Catherine A Spilling; Mohani-Preet K Dhillon; Daniel R Burrage; Sachelle Ruickbie; Emma H Baker; Thomas R Barrick; Paul W Jones
Journal:  PLoS One       Date:  2021-11-05       Impact factor: 3.240

2.  Effects of COPD on Left Ventricular and Left Atrial Deformation in Patients with Acute Myocardial Infarction: Strain Analysis Using Speckle-Tracking Echocardiography.

Authors:  Julian Grebe; Tobias Müller; Ertunc Altiok; Michael Becker; András P Keszei; Nikolaus Marx; Michael Dreher; Ayham Daher
Journal:  J Clin Med       Date:  2022-03-30       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.